Novavax (NVAX)
Novavax Days Inventory Outstanding
View NVAX Days Inventory Outstanding with YCharts Pro.
Access these YCharts Pro features:
Export any data you want
Save any chart as an image
Utilize advanced screener power
View 30 years of financial history
over 90 advanced calculations
Enjoy an advertising free experience
NVAX Days Inventory Outstanding Range, Past 5 Years
| Minimum | 532.59 | Jun 2007 |
| Maximum | 3582 | Sep 2007 |
| Average | 2057 |
About Days in Inventory
The average number of days a company holds inventory before selling it. This ratio is a measure of efficiency.
Learn More
You may also be interested in these NVAX related companies
NVAX News
NOVAVAX Launches Additional Phase I Clinical Trial of A/H5N1 Influenza Vaccine Candidate
May 09, 8:04AM Benzinga
May 09, 8:04AM Benzinga
$ZGNX and $GERN becoming even more interesting now $NVAX not so bad today
about 23 days ago by micheleciani
about 23 days ago by micheleciani
Market Wrap Video + Additions to Watch List http://stks.co/3iY4 including: $CAR $CPTS $GWR $NVAX $PBY $PPR
about 23 days ago by StockTiger
about 23 days ago by StockTiger
$NVAX http://stks.co/3iCA for a move to 200-day ok % gain if so -n Over $1.44 to 200-day
about 23 days ago by StockTiger
about 23 days ago by StockTiger
@Bleedblue i own both lol and $GALE is making me sad but $NVAX is making me happy
about 23 days ago by MisterDevin
about 23 days ago by MisterDevin
Listen to $NVAX Q1 2012 earnings call - live at 10:00 AM, ondemand after - http://stks.co/3flk
about 27 days ago by earningscast
about 27 days ago by earningscast
$NVAX Reports First Quarter 2012 Financial Results http://stks.co/3fh4 Good
about 27 days ago by micheleciani
about 27 days ago by micheleciani
Stock on our radar $ZGNX and $NVAX both more than +10% in the last few days
about 28 days ago by micheleciani
about 28 days ago by micheleciani
NOVAVAX Launches Phase I Clinical Trial of A/H5N1 Influenza Vaccine Candidate
May 02, 8:08AM Benzinga
May 02, 8:08AM Benzinga
Novavax (NVAX) Commences Enrollment in A/H5N1 Vaccine Candidate Phase I
May 02, 8:03AM Street Insider
May 02, 8:03AM Street Insider
@JVerns Yea. $NVAX not bad, a lot of volume, been holding that for a while. $GALE has huge upside, long wait though, I'll just cont. to add
about 30 days ago by MisterDevin
about 30 days ago by MisterDevin
@MisterDevin In the same boat. $NVAX could get even more interesting tomorrow
about 30 days ago by JVerns
about 30 days ago by JVerns
NOVAVAX to Present Results From Phase I RSV Study at XIV International Symposium on Respiratory Viral Infections
Mar 22, 9:52AM GlobeNewswire
Mar 22, 9:52AM GlobeNewswire
NOVAVAX Appoints John A. Herrmann III, Vice President and General Counsel
Mar 08, 9:00AM GlobeNewswire
Mar 08, 9:00AM GlobeNewswire
Novavax (NVAX) Commences Enrollment in Quadrivalent Seasonal VLP Phase II
Mar 01, 4:34PM Street Insider
Mar 01, 4:34PM Street Insider
NOVAVAX to Report 2011 Fourth-Quarter and Year-End Financial Results on March 9, 2012
Feb 24, 8:00AM GlobeNewswire
Feb 24, 8:00AM GlobeNewswire
Novavax (NVAX) India JV Makes Significant Vaccine-Development Program Progress
Jan 03, 8:17AM Street Insider
Jan 03, 8:17AM Street Insider
NOVAVAX Reports Progress Under Joint Venture in India With Cadila Pharmaceuticals
Jan 03, 8:06AM Benzinga
Jan 03, 8:06AM Benzinga
NOVAVAX to Present at 23rd Annual Piper Jaffray Health Care Conference
Nov 28, 12:17PM GlobeNewswire
Nov 28, 12:17PM GlobeNewswire
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| NVAX | 1.235 | -0.04 | -3.52% | 155.61M |
| NUV | 10.23 | +0.02 | +0.20% | |
| NUTR | 14.97 | -0.13 | -0.86% | 150.09M |
| NUS | 43.53 | +0.04 | +0.09% | 2.747B |
| NUROD | 0.74 | -0.01 | -1.33% | |
| NURO | 0.72 | -0.02 | -2.70% | 9.198M |
| NUO | 17.50 | +0.01 | +0.06% | |
| NUM | 15.41 | -0.01 | -0.06% | |
| NUE | 35.90 | -0.71 | -1.94% | 11.61B |
| NUCL | 31.31 | +0.16 | +0.52% |
